Reports Q2 revenue $8.7M, consensus $8.29M. Reports Installed base of Saphyr(R) systems totaled 281 as of June 30, 2023, which represents a 43% increase over Q2 2022″We are pleased with our Q2 2023 results, which include record revenues and consumable sales for any quarter in Bionano’s history,” commented Erik Holmlin, PhD, president and chief executive officer of Bionano. “We continue to see growing momentum in our business, and we believe our recent and upcoming major product releases should help us further penetrate new markets and achieve our business goals.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BNGO:
- Bionano Reports Second Quarter 2023 Results and Highlights Recent Business Progress
- Bionano Genomics options imply 13.1% move in share price post-earnings
- Bionano Genomics Announces Reverse Stock Split
- Bionano Genomics effects 1-for-10 reverse stock split
- Bionano to Report Second Quarter 2023 Financial Results and Host a Conference Call and Webcast on August 9, 2023